Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Reexamination Certificate
2006-10-12
2010-02-02
Nguyen, Quang (Department: 1633)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
C435S455000, C435S320100, C435S368000
Reexamination Certificate
active
07655224
ABSTRACT:
The present invention is based upon a surprising finding that stem cells, more particularly neural stem cells, can migrate throughout a brain tumor and track metastatic brain tumor cells. The invention provides a method for treating brain tumors by administering genetically engineered neural stem cells in an individual affected by brain tumors. The invention also provides a method of preparing genetically engineered neural stem cells and a composition comprising genetically engineered neural stem cells in a pharmaceutically acceptable carrier.
REFERENCES:
patent: 5585096 (1996-12-01), Martuza et al.
patent: 5624830 (1997-04-01), Mullen et al.
patent: 5750376 (1998-05-01), Weiss et al.
patent: 5753506 (1998-05-01), Jobe
patent: 5851832 (1998-12-01), Weiss et al.
patent: 6258353 (2001-07-01), Isacson et al.
patent: 6969608 (2005-11-01), Miller et al.
patent: 2002/0006660 (2002-01-01), Sabate et al.
Park et al. Global gene and cell replacement strategies via stem cells. Gene therapy 9:613-624, 2002.
Noble, M. Can neural stem cells be used to track down and destroy migratory brain tumor cells while also providing a menas of repairing tumor-associated damage? PNAS 97:12393-12395, 2000.
Noble, M. Can neural stem cells be used as therapeutic vehicles in the treatment of brain tumors? Nature Medicine 6:369-370, 2000.
Randazzo et al. Treatment of experimental intracranial murine melanoma with a neuroattenuated herpes simplex virus 1 mutant. Virology 211:94-101, 1996.
Snyder, E., et al.,Nature(London) 374:367-370, 1995.
Weiss, S., et al.,Trends Neurosci.19:387-393, 1996.
McKay, R.,Science276:66-71, 1997.
Snyder, E., et al.,Proc. Natl. Acad. Sci. USA94:11663-11668, 1997.
Flax, J.D., et al.,Nat. Biotech. 16: 1033-1039, 1998.
Topf, N., et al.,Gene Ther. 5:507-513, 1998.
Cage, et al.Am. Rev. Neurosci. 18:159-192, 1995.
Wittemore, et al.,Molecular Neurobiology12:13-39, 1996.
Snyder,The Neuroscientist4:408-425, 1998.
Snyder, et al.,Cell68:33-51, 1992.
Renfranz, et al.,Cell66:713-729, 1991.
Snyder, et al.,Current Opin. In Pediatrics8:558-568, 1996.
Park, J.Neurotrauma16:675-687,1999.
Aboody-Guterman, et al.,Neuro Report8:3801-3808, 1997.
Aboody Karen S.
Breakefield Xandra O.
Herrlinger Ulrich
Lynch William P.
Snyder Evan Y.
Children's Medical Center Corp.
Nguyen Quang
Nixon & Peabody LLP
Northeastern Ohio Universities COM
The General Hospital Corp.
LandOfFree
Neural stem cells and use thereof for brain tumor therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Neural stem cells and use thereof for brain tumor therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neural stem cells and use thereof for brain tumor therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4218880